Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension

被引:17
|
作者
Mese, Timur [1 ]
Guven, Baris [2 ]
Yilmazer, Murat Muhtar [1 ]
Karadeniz, Cem [3 ]
Ozdemir, Rahmi [1 ]
Doksoz, Onder [1 ]
机构
[1] Univ Hlth Sci, Dept Pediat Cardiol, Dr Behcet Uz Childrens Hosp, Fac Med, Izmir, Turkey
[2] Univ Hlth Sci, Dept Pediat Cardiol, Izmir Tepecik Training Hosp, Fac Med, Izmir, Turkey
[3] Katip Celebi Univ, Div Pediat Cardiol, Fac Med, Izmir, Turkey
关键词
congenital heart disease; mean platelet volume; platelet activation; pulmonary hypertension; DISTRIBUTION WIDTH; VOLUME; SURVIVAL; THERAPY; INDEXES; REGISTRY;
D O I
10.1111/chd.12616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mean platelet volume (MPV), platecrit, and platelet distribution width (PDW) are markers of platelet activation. Previous studies have found that platelet activation occurs in patients with pulmonary arterial hypertension. Platelet indices including MPV, PDW, and platecrit have not been studied in children with congenital heart disease associated pulmonary arterial hypertension (APAH-CHD) who survived and those who died. Objective: The objective of this study to investigate the value of platelet indices with clinical and hemodynamic indicators predicting the disease severity and survival in children with APAH-CHD. Methods: This was a nested case-control study. MPV, platecrit, and PDW levels measured in 37 patients with APAH-CHD and 43 healthy subjects at the beginning of the study. Right heart catheterization was performed in all 37 patients. Clinical and hemodynamic data were collected. All patients were followed from the date of laboratory testing. The study was conducted between March 2012-July 2015. The comparison of clinical, hemodynamic data and platelet indices were made between patients with APAH-CHD who died than APAH-CHD patients who survived. Results: Of 37 patients, after a mean follow-up duration of 67.90647.90 months, 11 patients died. MPV (12.10 femoliter [fL; 8.20-12.50] vs 8.70 fL [6.40-9.70], P5.007), PDW (16.88 +/- 1.09% vs 15.75 +/- 1.58%, P = .04) and platecrit (0.28 +/- 0.31 vs 0.22 +/- 0.27, P = .01) were significantly higher in the patients with APAH-CHD who died than those who survived. Pearson's correlation analysis showed that MPV correlated with mean pulmonary artery pressure (r = 0.332, P = .04) and correlated negatively with six-minute walking distance (r = -0.600. P = .00). PDW and platecrit correlated positively with mean pulmonary artery pressure (r = 0.373, P = .02; r = 0.389, P = .01, respectively). Conclusion: Our results showed that MPV, platecrit and PDW were increased in children with APAH-CHD. They might give clue about disease severity.
引用
收藏
页码:506 / 511
页数:6
相关论文
共 50 条
  • [1] Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Awad, Abdulhalim
    Elnemr, Shimaa
    Hodeib, Hossam
    El Amrousy, Doaa
    [J]. PEDIATRIC CARDIOLOGY, 2022, 43 (06) : 1264 - 1270
  • [2] Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Abdulhalim Awad
    Shimaa Elnemr
    Hossam Hodeib
    Doaa El Amrousy
    [J]. Pediatric Cardiology, 2022, 43 : 1264 - 1270
  • [3] Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Zuckerman W.A.
    Krishnan U.
    Rosenzweig E.B.
    [J]. Current Pediatrics Reports, 2013, 1 (2) : 92 - 101
  • [4] Pulmonary arterial hypertension associated with congenital heart disease
    D'Alto, Michele
    Mahadevan, Vaikom S.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2012, 21 (126): : 328 - 337
  • [5] Congenital heart disease associated pulmonary arterial hypertension
    Landzberg, Michael J.
    [J]. CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 243 - +
  • [6] Pulmonary arterial hypertension associated with congenital heart disease
    Kulik, Tom
    Mullen, Mary
    Adatia, Ian
    [J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 2009, 27 (1-2) : 25 - 33
  • [7] Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Krishnan, Usha
    Rosenzweig, Erika B.
    [J]. CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 707 - +
  • [8] Pulmonary Hypertension/Pulmonary arterial Hypertension in congenital Heart Disease and Therapy of pulmonary arterial Hypertension in Children
    Gorenflo, M.
    Apitz, C.
    Miera, O.
    Stiller, B.
    Schranz, D.
    Berger, F.
    Hager, A.
    Kaemmerer, H.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S166 - S170
  • [9] Effect of bosentan in children with pulmonary arterial hypertension associated with congenital heart disease
    Rosenzweig, E. Berman
    Ivy, D. D.
    Doran, A. K.
    Claussen, L. R.
    Yung, D.
    Widlitz, A. C.
    Abman, S.
    Barst, R. J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 617 - 617
  • [10] Factors associated with the uncorrectable congenital heart disease in children with pulmonary arterial hypertension
    Handoyo
    Gunawijaya, Eka
    Yantie, Ni Putu Veny Kartika
    [J]. MEDICAL JOURNAL OF INDONESIA, 2023, 32 (01) : 38 - 44